image
Healthcare - Biotechnology - NASDAQ - US
$ 0.3269
-7.84 %
$ 40.7 M
Market Cap
-0.58
P/E
Price Target Average
817.71%
Revenue Forecast Estimate
59.46%
EBIT Estimate
--37.46%
Net Income Estimate
21.90%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets Mersana Therapeutics, Inc.
image
Wall Street analysts predict an average 1-year price target for MRSN of $3 , with forecasts ranging from a low of $3 to a high of $3 .
MRSN Lowest Price Target Wall Street Target
3 USD 817.71%
MRSN Average Price Target Wall Street Target
3 USD 817.71%
MRSN Highest Price Target Wall Street Target
3 USD 817.71%
Price
Max Price Target
Min Price Target
Average Price Target
444433332222111100Jun '24Jun '24Jul '24Jul '24Aug '24Aug '24Oct '24Oct '24Nov '24Nov '2420252025Feb '25Feb '25Apr '25Apr '25Jun '25Jun '25Jul '25Jul '25Aug '25Aug '25Oct '25Oct '25Nov '25Nov '2520262026Feb '26Feb '26Apr '26Apr '26
REVENUE FORECAST

Revenue Forecast Chart MRSN

image
$300.0m$300.0m$250.0m$250.0m$200.0m$200.0m$150.0m$150.0m$100.0m$100.0m$50.0m$50.0m$0.0$0.020172017201820182019201920202020202120212022202220232023202420242025202520262026202720272028202820292029
EBIT FORECAST

EBIT Forecast Chart MRSN

image
$0.0$0.0($50.0m)($50.0m)($100.0m)($100.0m)($150.0m)($150.0m)($200.0m)($200.0m)($250.0m)($250.0m)($300.0m)($300.0m)20172017201820182019201920202020202120212022202220232023202420242025202520262026202720272028202820292029
NET INCOME FORECAST

Net Income Chart MRSN

image
$800.0m$800.0m$600.0m$600.0m$400.0m$400.0m$200.0m$200.0m$0.0$0.0($200.0m)($200.0m)($400.0m)($400.0m)20172017201820182019201920202020202120212022202220232023202420242025202520262026202720272028202820292029